$72.09
-5.81-7.46%
At close: Aug 28, 5:00 PM EST
Cytokinetics Inc
CYTKNASDAQ
PRO
Cytokinetics Earnings & Forecasts
Cytokinetics (CYTK) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
Cytokinetics Guidance
Cytokinetics (CYTK) last issued guidance on February 27, 2024 for fiscal year 2024. The company guided revenue in the range of $3M - $5M for the period.
Compared to prior guidance, Cytokinetics lowered its revenue forecast from a prior range of $5M - $5M.
Cytokinetics has issued 2 guidance updates between March 1, 2023 and February 27, 2024. During this period, the company lowered its outlook 1 time, signaling management's revised expectations.
Recent Earnings Results
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-1.62 | $-1.65 | $-1.41 | $-1.58 |
| Actual | $-1.50 | $-1.67 | $-1.50 | $-1.54 |
| Surprise | +7.41% | -1.21% | -6.38% | +2.53% |
| Revenue | ||||
| Estimate | $17.2M | $8.5M | $6.4M | $5.9M |
| Actual | $28.6M | $19.4M | $17.8M | $1.9M |
| Surprise | +66.0% | +128.1% | +178.7% | -66.9% |
Analyst Estimates — Forward PeriodsSource: Wall Street consensus
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-1.45 | $-1.42 | $-1.46 | $-1.33 |
| Revenue | ||||
| Consensus | $39.7M | $59.4M | — | — |
